Metastatic Cancer Clinical Trials in Durham, North Carolina
6 recruitingDurham, North Carolina
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Breast CancerBreast Cancer MetastaticOvarian Cancer+6 more
Incyclix Bio150 enrolled18 locationsNCT05735080
Recruiting
Phase 1Phase 2
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ovarian CancerEndometrial CancerProstate Cancer+5 more
PMV Pharmaceuticals, Inc300 enrolled76 locationsNCT04585750
Recruiting
Phase 2
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Metastatic CancerAdvanced CancerMalignant Neoplasm of Lung
Mirati Therapeutics Inc.200 enrolled120 locationsNCT05853575
Recruiting
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Metastatic CancerOligometastasis
Duke University300 enrolled5 locationsNCT04085029
Recruiting
Phase 3
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Metastatic CancerAdvanced Cancer
Daiichi Sankyo50 enrolled28 locationsNCT06174987
Recruiting
Phase 1
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Metastatic CancerAdvanced CancerSolid Tumor
Memgen, Inc.40 enrolled2 locationsNCT05076760